VascuMind CRO Licensing One-Pager
A concise commercial packet for CROs, sponsors, and trial networks evaluating vascular cognitive screening and trial-readiness infrastructure.
Problem
Vascular cognitive impairment, mixed cognitive impairment, and MCI trial programs need earlier, more operationally useful cognitive screening than generic late-stage cognitive tools can provide.
VascuMind / MCI Screen fit
VascuMind acts as the vascular cognitive education and trial-readiness funnel, while MCI Screen supports structured cognitive screening workflows.
Commercial model
MoCA benchmark: approximately $35,000 plus $35/test. VascuMind should anchor at parity or premium when supported by evidence and implementation scope.
Pilot structure
A pilot should define indication, site count, participant volume, screening workflow, data handoff, reporting cadence, and compliance requirements before launch.
Suggested licensing tiers
| Tier | License | Per-test | Best fit |
|---|---|---|---|
| Pilot | $35k–$50k | $35–$50 | Single-study feasibility |
| Standard | $75k | $50–$75 | Active trial program |
| Enterprise | Custom | Custom | Multi-study or multi-region deployment |
Next step
Request a structured licensing discussion to define indication, sites, participant volume, timeline, and implementation scope.
Request Licensing Packet